Durability and Safety of CCH With Two Different Injection Techniques in Cellulite With Laxity

Endo Pharmaceuticals

Status: Completed

Conditions: Laxity; Skin; Cellulite; Edematous Fibrosclerotic Panniculopathy

Study type: Observational

Funder types: Industry

Identifiers

NCT05249257

EN3835-225

Details and patient eligibility

About

All participants who completed the EN3835-224 study will be invited to participate in this observational study to evaluate long term durability of response and safety.

Enrollment: 20 patients

Sex: Female

Ages: 18 to 55 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Have participated in and completed study EN3835-224 (parent study).
2. Be willing and able to cooperate with the requirements of the study.

Exclusion criteria

1. Has received any collagenase treatments (eg, Santyl® Ointment) at any time since
2. Has had any surgery, invasive procedure (eg, liposuction), injectable treatment (eg, KYBELLA®) or any similar treatment in the area treated during the EN3835-224 study since the completion of that study.
3. Has any other conditions that, in the investigator's opinion, might indicate the participant to be unsuitable for the study

Trial design

20 participants in 1 patient group

No Treatment - previously treated in parent study

Description:

Participants who completed the parent study EN3835-224 (NCT04580303) will be eligible for this study.